ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006

NCAB Committee Approved Concepts For D Contracts

December 7, 1984

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

NCAB Committee Ok’s Recompetition of OD Support Contract

May 22, 1992

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003